Cyclo Therapeutics, Inc. CYTHW
At closeMar 25, 2025, 4:00 PM EDT
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 928.01K
- Revenue (ttm)
- 1.13M
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 28.41K
- Avg volume
- 12.32K
- Open
- 0.0697
- Previous close
- 0.032
- Day's range
- 0.032 – 0.032
- 52-week range
- 0.025 – 0.614
- Beta
- -0.38
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.75
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.10%
- Free cash flow
- -10.79M
- Total cash
- 1.12M
- Total debt
- 3.00M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.1639
- 200-day average
- 0.19289
Next earnings
Consensus EPS estimate 0.00.
About Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- cyclotherapeutics.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CYTHW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Citadel Advisors Llc | 0.50% | 11,593 | 1.45K | Sep 29, 2024 |
| Bank of America Corporation | 0.01% | 144 | 17 | Sep 29, 2024 |